![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Expert Committee Recommends Patient-Focused Dissolution Standards
Expert Committee Recommends Patient-Focused Dissolution Standards
September 21, 2018
An FDA advisory panel voted unanimously to recommend that the agency establish patient-focused dissolution standards for extended-release solid oral dosage forms.
In the 11-0 vote, members of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee affirmed the need for such standards within the industry.
“There’s no question this would be a valuable scientific enterprise and, properly explained to the public, I believe it’s something that’s going to have wide support,” said temporary voting member Paul J. Smith, director of the University of Maryland’s statistics program.
Upcoming Events
-
21Oct